Related Experiment Video
Updated: Jan 11, 2026
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Rare Neuromelioidosis Case that Required Long Intensive Phase Therapy
Samhita Ankala1, Thomas John2, Binoj Varghese3
1Radiology Residency Programme, Amala Institute of Medical Sciences, Thrissur, India.
Abstract:
Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is endemic in tropical regions, including the Indian subcontinent. It can affect several systems in the body and has high mortality and morbidity. Neuromelioidosis is a rare central nervous system manifestation of melioidosis. We report a case of a 37-year-old man who had disseminated melioidosis with severe central nervous system involvement, with radiological demonstration of spread along white matter tracts. Our report emphasizes the importance of prolonged intensive phase therapy in achieving clinical remission and preventing relapse.
Insights
Melioidosis, a serious infectious disease caused by Burkholderia pseudomallei, can severely affect the central nervous system. Prolonged intensive therapy is crucial for treating disseminated melioidosis and preventing relapses.
Area of Science:
- Infectious Diseases
- Neurology
- Microbiology
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is prevalent in tropical areas like the Indian subcontinent.
- This infectious disease presents significant mortality and morbidity, affecting multiple organ systems.
- Neuromelioidosis, a rare central nervous system complication, poses diagnostic and therapeutic challenges.
